2015 Optometry's Meeting Course Recording - Does it really matter if patients get the originally developed ophthalmic agent or a generic? The answers are certainly uncertain! This course will take a look at the FDA ophthalmic drug development and drug approval process and the different routes for brand and generics equivalents. You will be presented with a review the current generic vs branded controversies that often raise concerns about the use of generic formulations and will present data on current legal controversies.
June 27, 2015
By clicking the box, I certify that I am the person who logged in to AOA's EyeLearn and will personally view this course.